Search

Your search keyword '"FINASTERIDE"' showing total 7,267 results

Search Constraints

Start Over You searched for: Descriptor "FINASTERIDE" Remove constraint Descriptor: "FINASTERIDE"
7,267 results on '"FINASTERIDE"'

Search Results

10. 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy

12. Effects of algerian nettle (Urtica dioica L.) on benign prostatic hyperplasia and their mechanism of action elucidation: in vivo and in silico approaches.

13. 1 565 nm非剥脱点阵激光在雄激素性秃发中的 临床疗效观察.

14. Hybrid hair follicle stem cell extracellular vesicles co-delivering finasteride and gold nanoparticles for androgenetic alopecia treatment.

15. Patient‐reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data.

16. Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial

21. In vivo assessment of the anti-benign prostatic hyperplasia effect of hot ethanolic extract of flax seeds in male rats

22. Change in prostate tissue gene expression following finasteride or doxazosin administration in the medical therapy for prostatic symptoms (MTOPS) study

23. The Role of Reactive Oxygen Species, Inflammation, and Endoplasmic Reticulum Stress Response in the Finasteride Protective Effect against Benign Prostate Hyperplasia

24. In vivo assessment of the anti-benign prostatic hyperplasia effect of hot ethanolic extract of flax seeds in male rats.

25. Determination of optimal dosage of extract of Angelica gigas Nakai against benign prostatic hyperplasia.

26. Intraoperative Iris Behavior during Phacoemulsification Maneuvers in Rabbits Treated with Selective α1-Blocker, 5α-Reductase Inhibitor, or Anxiolytic Medication.

27. Electrochemical Behavior of Finasteride on Glassy Carbon Electrode Using Differential Pulse Voltammetric Technique.

28. Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study.

29. Spironolactone, bicalutamide, and dutasteride as a treatment option for androgenetic alopecia.

31. A Phase I, Open-Label, Sequential, Single-Dose Clinical Trial to Evaluate the Pharmacokinetic, Pharmacodynamic, and Safety of IVL3001, a Finasteride-Based Novel Long-Acting Injection for Androgenetic Alopecia.

32. Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies.

33. Anxiety-, and depression-like behavior following short-term finasteride administration is associated with impaired synaptic plasticity and cognitive behavior in male rats.

34. Add or switch to systemics and biologics where topical paediatric hidradenitis suppurativa therapy fails.

35. Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management.

40. Persistent Gynecomastia due to Short-term Low-dose Finasteride for Androgenetic Alopecia.

41. Topical solutions for androgenetic alopecia: evaluating efficacy and safety.

42. Medical Treatment for Androgenetic Alopecia.

43. Therapeutic maintenance effect of finasteride 1 mg every other month regimen in androgenetic alopecia and study on the difference in response to finasteride treatment: A prospective cohort study.

44. Adverse effects of the 5-alpha-reductase inhibitor finasteride on Daphnia magna: Endocrine system and lipid metabolism disruption

45. Post‐finasteride syndrome: real or myth?

46. The Role of Topical Finasteride in Hair Loss Management: Current Evidence and Future Perspectives

47. Androgenetic alopecia: An updateCapsule Summary

49. Men and hair loss: A guide for primary care nurses.

50. Researcher from Texas Tech University Health Sciences Center Reports on Findings in Biogenic Amines (Epigenetic Effects of Finasteride on Dopaminergic Signaling Pathways: A potential contributor to Post-Finasteride Syndrome)

Catalog

Books, media, physical & digital resources